Related Experiment Video

Updated: Jun 6, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

Ankur Sharma1, Wen-Shuz Yeow, Adam Ertel

  • 1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

The Journal of Clinical Investigation
|November 25, 2010
PubMed

Insights

The retinoblastoma tumor suppressor (RB) protects against prostate cancer progression by regulating androgen receptor (AR) activity. Loss of RB function promotes castration-resistant prostate cancer and therapeutic resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Retinoblastoma (RB) protein, encoded by RB1, is a key tumor suppressor regulating cell cycle progression.
  • The precise role of RB in tumor progression, particularly in prostate cancer, remains incompletely understood.
  • RB dysfunction is linked to advanced and treatment-resistant cancer states.

Purpose of the Study:

  • To elucidate the role of RB in prostate cancer progression beyond cell cycle control.
  • To investigate the mechanisms by which RB loss contributes to castration-resistant prostate cancer (CRPC).
  • To identify novel therapeutic targets by understanding the RB pathway in prostate cancer.

Main Methods:

  • Analysis of human prostate cancer patient samples.
  • In vitro and in vivo modeling of RB dysfunction.
  • Investigation of RB's regulation of nuclear receptor networks, including androgen receptor (AR).
  • Assessment of the E2F transcription factor 1 (E2F1) role in RB-mediated regulation.

Main Results:

  • RB loss is infrequent in primary prostate cancer but prevalent in castration-resistant disease, correlating with poor outcomes.
  • RB loss facilitates tumor progression by dysregulating nuclear receptor networks, specifically via E2F1-mediated control of AR.
  • RB depletion leads to increased AR activity, driving therapeutic bypass and tumor progression.
  • Disruption of the RB/E2F/nuclear receptor axis is common in therapy-resistant prostate cancer.

Conclusions:

  • RB plays a critical role in suppressing prostate tumor progression and lethal phenotypes through non-cell cycle-related mechanisms.
  • The RB/E2F1/AR pathway represents a novel mechanism by which RB controls prostate cancer progression and therapy resistance.
  • Targeting the RB/E2F/nuclear receptor axis may offer new therapeutic strategies for advanced prostate cancer.

More Related Videos

Reconstruct Human Retinoblastoma In Vitro06:52

Reconstruct Human Retinoblastoma In Vitro

Published on: October 11, 2022

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...